These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22018620)

  • 1. The cities study: conventional immunotherapy-investigating existing schedules.
    Baker TW; Webber CM; Tankersley MS
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):460-2. PubMed ID: 22018620
    [No Abstract]   [Full Text] [Related]  

  • 2. Shooting for a faster approach to the immunotherapy target: will cluster become conventional?
    Cox LS
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):177-8. PubMed ID: 19354062
    [No Abstract]   [Full Text] [Related]  

  • 3. Fungal immunotherapy in patients with allergic fungal sinusitis.
    Greenhaw B; deShazo RD; Arnold J; Wright L
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):432-6. PubMed ID: 22018615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rush allergen subcutaneous immunotherapy administered with infusion pump.
    Sastre J; Vallejo L; Hernández E; Fernández-Nieto M; Nieto PR
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):459-60. PubMed ID: 22018619
    [No Abstract]   [Full Text] [Related]  

  • 5. Some highlights of the first century of immunotherapy.
    Nelson HS
    Ann Allergy Asthma Immunol; 2011 Nov; 107(5):417-21. PubMed ID: 22018612
    [No Abstract]   [Full Text] [Related]  

  • 6. Subcutaneous injection immunotherapy for optimal effectiveness.
    Nelson HS
    Immunol Allergy Clin North Am; 2011 May; 31(2):211-26, viii. PubMed ID: 21530815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspiration before immunotherapy injection is required.
    Geller M
    J Allergy Clin Immunol; 2007 Jul; 120(1):220-1; author reply 221. PubMed ID: 17418378
    [No Abstract]   [Full Text] [Related]  

  • 8. [Allergen-specific immunotherapy].
    Hansen TK; Svendsen UG
    Ugeskr Laeger; 2005 Feb; 167(6):666-71. PubMed ID: 15771384
    [No Abstract]   [Full Text] [Related]  

  • 9. Subcutaneous and sublingual immunotherapy and T regulatory cells: there is clinical relevance.
    Ciprandi G; Morandi F; Olcese R; Silvestri M; Tosca MA
    Clin Exp Allergy; 2010 Oct; 40(10):1578-9; author reply 1579-80. PubMed ID: 20937063
    [No Abstract]   [Full Text] [Related]  

  • 10. Half of systemic reactions to allergen immunotherapy are delayed, majority require treatment with epinephrine.
    Cook KA; Ford CM; Leyvas EA; Waalen J; White AA
    J Allergy Clin Immunol Pract; 2017; 5(5):1415-1417. PubMed ID: 28454684
    [No Abstract]   [Full Text] [Related]  

  • 11. Cluster protocols in SCIT: enough evidence for practical use?
    Pfaar O; Leitzbach S; Hörmann K; Klimek L
    Curr Opin Allergy Clin Immunol; 2010 Jun; 10(3):188-93. PubMed ID: 20410818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring the effect of allergen immunotherapy: a clinician's dream comes true?
    Bullens DM
    Clin Exp Allergy; 2010 Jul; 40(7):958-61. PubMed ID: 20642573
    [No Abstract]   [Full Text] [Related]  

  • 13. The LOCAL Study: Local reactions do not predict local reactions in allergen immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2009 Oct; 124(4):739-44. PubMed ID: 19767075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional regulatory T cells and allergen immunotherapy.
    Rolland JM; Gardner LM; O'Hehir RE
    Curr Opin Allergy Clin Immunol; 2010 Dec; 10(6):559-66. PubMed ID: 20859202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic tolerability of specific subcutaneous immunotherapy with index-of-reactivity-standardized allergen extracts administered using clustered regimens: a retrospective, observational, multicenter study.
    Serrano P; Justicia JL; Sánchez C; Cimarra M; Fernández-Távora L; Orovitg A; Moreno C; Guerra F; Alvà V
    Ann Allergy Asthma Immunol; 2009 Mar; 102(3):247-52. PubMed ID: 19354072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages and disadvantages of accelerated immunotherapy schedules.
    Cox L
    J Allergy Clin Immunol; 2008 Aug; 122(2):432-4. PubMed ID: 18619664
    [No Abstract]   [Full Text] [Related]  

  • 17. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy.
    Cochard MM; Eigenmann PA
    J Allergy Clin Immunol; 2009 Aug; 124(2):378-9. PubMed ID: 19541352
    [No Abstract]   [Full Text] [Related]  

  • 18. Sublingual immunotherapy and subcutaneous immunotherapy: issues in the United States.
    Greenberger PA; Ballow M; Casale TB; Platts-Mills TA; Sampson HA
    J Allergy Clin Immunol; 2007 Dec; 120(6):1466-8. PubMed ID: 17936891
    [No Abstract]   [Full Text] [Related]  

  • 19. Hyposensitization.
    Saeed SA
    J Coll Physicians Surg Pak; 2005 Apr; 15(4):250. PubMed ID: 15912630
    [No Abstract]   [Full Text] [Related]  

  • 20. [Rush desensitization to drugs: elements for protocol rationalization].
    Moneret-Vautrin DA; Kanny G; Beaudouin E
    Allerg Immunol (Paris); 1999 Mar; 31(3):73-8. PubMed ID: 10226680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.